Logo (WIPO, 08/19/2020)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark was filed as Figurative mark on 08/19/2020 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Armillary spheres, planetaria, astronomic orbits, atomic models, molecular models #Colours #Atomic models, molecular models, representations of human, animal or vegetal cells #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1562218 |
| Countries | 
|
| Base trademark |
No. 88829932,
March 11, 2020
|
| Application date | August 19, 2020 |
| Expiration date | August 19, 2030 |
Trademark owner
215 First Street
Cambridge MA 02142
US
Cambridge MA 02142
US
Trademark representatives
250 West 55th Street
New York NY 10019-9710
US
goods and services
01
Chemical compounds and additives for use in pharmaceutical
research; chemical compounds and additives for use in the
manufacture of pharmaceuticals; diagnostic reagents for
research use
05
Pharmaceutical preparations for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations based on
morpholino oligomer technology platform for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders, and for the regulation of protein
production; pharmaceutical preparations that modulate RNA
expression for the treatment of neuromuscular diseases and
disorders, muscular dystrophies, central nervous system
diseases and disorders, genetic diseases and disorders, and
for the regulation of protein production; gene therapy
products, namely, gene delivery pharmaceuticals;
pharmaceutical preparations for gene therapy, gene editing,
and genome editing; gene therapy products for the treatment
of neuromuscular diseases and disorders, muscular
dystrophies, central nervous system diseases and disorders,
genetic diseases and disorders; biological preparations for
the treatment of neuromuscular diseases and disorders,
muscular dystrophies, central nervous system diseases and
disorders, genetic diseases and disorders; viruses, viral
vectors and viral constructs for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations,
biological preparations and gene therapy products in the
nature of pharmaceutical and biological preparations for the
treatment of genetic disorders and diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 12, 2023 | 2023/22 Gaz | US | RAW: Partial Ceasing Effect |
| April 28, 2022 | 2022/18 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 28, 2022 | 2022/13 Gaz | IS | Rejection |
| October 21, 2021 | 2021/42 Gaz | JP | Rejection |
| October 20, 2021 | 2021/42 Gaz | CH | Rejection |
| September 30, 2021 | 2021/39 Gaz | NO | Rejection |
| September 21, 2021 | 2021/38 Gaz | BR | Rejection |
| April 15, 2021 | 2021/15 Gaz | EM | Rejection |
| March 31, 2021 | 2021/13 Gaz | GB | Rejection |
| August 19, 2020 | 2020/46 Gaz | US | Registration |
ID: 141562218